A journal has issued an expression of concern for a 2014 paper on a study of a potential treatment for autism.
The article, by a group in Slovakia, purported to show for the first time that the drug ubiquinol — a form of the compound coenzyme Q₁₀ — could improve the ability of children with autism to communicate with their parents, communicate verbally, play games with other children and help with other behaviors.
The paper was published in Oxidative Medicine and Cellular Longevity, a Hindawi journal. The first author was Anna Gvozdjáková, of Comenius University in Bratislava, and the last author was Fred Crane, a former biologist at Purdue University in Indiana. Crane, who died in 2016, is credited with being the discoverer of coenzyme Q10 in mitochondria in 1957. The 2014 article — which has been cited 29 times, according to Clarivate Analytics’ Web of Science — was among the last of his 400-plus papers to appear in print.
Per the EoC:
Continue reading Journal expresses concern over study of potential treatment for autism